Originally posted here:
Sandoz submits Biologics License Application for proposed biosimilar trastuzumab to US FDA
Category Archives: Global News Feed
ProQR Announces Amendment to Convertible Debt Financing Agreement with Pontifax Ventures and Kreos Capital
Read more from the original source:
ProQR Announces Amendment to Convertible Debt Financing Agreement with Pontifax Ventures and Kreos Capital
Denali Therapeutics to Present New Data on ETV:IDS (DNL310) for the Potential Treatment of Hunter Syndrome at WORLDSymposium™
T2 Biosystems Reminds Stockholders to Vote at the Upcoming Annual Meeting
See original here:
T2 Biosystems Reminds Stockholders to Vote at the Upcoming Annual Meeting
Codexis to Participate in Upcoming Virtual Healthcare Conferences
Read the rest here:
Codexis to Participate in Upcoming Virtual Healthcare Conferences
Valneva – Déclaration d’actions et de droits de vote – Janvier 2021
Trading in Novo Nordisk shares by board members, executives and associated persons on 3-4 February 2021
BioCardia Issued New U.S. Patent for Technology that Enhances Control for Cardiac Therapies
Read more from the original source:
BioCardia Issued New U.S. Patent for Technology that Enhances Control for Cardiac Therapies
Franciosi Consulting Assessing New Potential Treatments for Asthma and COPD
Arecor Limited: First Patient Dosed in Phase I Clinical Trial of Ultra-Concentrated Rapid Acting Insulin Candidate, AT278, for Diabetes
Polydex Pharmaceuticals Issues Third Quarter Financial Results
BioRestorative Therapies Emerges from Chapter 11 Reorganization
Read more here:
BioRestorative Therapies Emerges from Chapter 11 Reorganization
vTv Therapeutics Announces Topline Results of Phase 2 Elevage Study of Azeliragon in Patients with Mild Alzheimer’s Disease and Type 2 Diabetes
Tauriga Sciences Inc. Updates Shareholders on Progress Pursuant to the Collaboration Agreement with Aegea Biotechnologies Inc. for New COVID-19…
Auris Medical Launches Website for AM-301-focused Subsidiary, Altamira Medica
Ovid Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Neuronetics to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum
LIDDS Interim report January – September 2020
Follow this link:
LIDDS Interim report January – September 2020
Novan to Present at the Virtual Investor KOL Roundtable
Go here to see the original:
Novan to Present at the Virtual Investor KOL Roundtable